Safety evaluation of the single-dose Ad26. COV2.S vaccine among healthcare workers in the Sisonke study in South Africa : a phase 3b implementation trial
Loading...
Date
Authors
Takuva, Simbarashe G.
Takalani, Azwidhwi
Seocharan, shen
Yende-Zuma, Nonhlanhla
Reddy, Tarylee
Engelbrecht, Imke
Faesen, Mark
Khuto, Kentse
Whyte, Carmen J.
Bailey, Veronique
Journal Title
Journal ISSN
Volume Title
Publisher
Public Library Science
Abstract
Real-world evaluation of the safety profile of vaccines after licensure is crucial to accurately
characterise safety beyond clinical trials, support continued use, and thereby improve public
confidence. The Sisonke study aimed to assess the safety and effectiveness of the Janssen
Ad26.COV2.S vaccine among healthcare workers (HCWs) in South Africa. Here, we present the safety data.
Description
Keywords
Safety, Effectiveness, Vaccines, Janssen Ad26.COV2.S vaccine, Healthcare workers (HCW), South Africa (SA)
Sustainable Development Goals
Citation
Takuva, S., Takalani, A., Seocharan, I., Yende-Zuma, N., Reddy, T., Engelbrecht, I. et al. (2022) Safety evaluation of the single-dose Ad26.COV2.S
vaccine among healthcare workers in the Sisonke
study in South Africa: A phase 3b implementation trial. PLoS Medicine 19(6): e1004024. https://doi.org/10.1371/journal.pmed.1004024.